Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FLT3 |
Variant | D586_D593delinsGG |
Impact List | indel |
Protein Effect | unknown |
Gene Variant Descriptions | FLT3 D586_D593delinsGG results in a deletion of eight amino acids in the juxtamembrane domain of the Flt3 protein from amino acids 586 to 593, combined with the insertion of two glycines (G) at the same site (PMID: 37246158). D586_D593delinsGG results in Flt3 phosphorylation similar to wild-type Flt3 in culture (PMID: 37246158), but has not been fully biochemically characterized and therefore, its effect on Flt3 protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
FLT3 mutant FLT3 exon14 FLT3 D586_D593delinsGG |
Transcript | NM_004119.2 |
gDNA | chr13:g.28034140_28034163delinsACCACC |
cDNA | c.1756_1779delinsGGTGGT |
Protein | p.D586_D593delinsGG |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004119.2 | chr13:g.28034140_28034163delinsACCACC | c.1756_1779delinsGGTGGT | p.D586_D593delinsGG | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FLT3 D586_D593delinsGG | hematologic cancer | predicted - sensitive | Quizartinib | Preclinical - Biochemical | Actionable | In a preclinical study, Vanflyta (quizartinib) inhibited Flt3 phosphorylation in cells expressing FLT3 D586_D593delinsGG in culture (PMID: 37246158). | 37246158 |
FLT3 D586_D593delinsGG | hematologic cancer | predicted - sensitive | Sorafenib | Preclinical - Biochemical | Actionable | In a preclinical study, Nexavar (sorafenib) inhibited Flt3 phosphorylation in cells expressing FLT3 D586_D593delinsGG in culture (PMID: 37246158). | 37246158 |